Your browser doesn't support javascript.
loading
DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.
Gampenrieder, Simon Peter; Rinnerthaler, Gabriel; Hackl, Hubert; Pulverer, Walter; Weinhaeusel, Andreas; Ilic, Suzana; Hufnagl, Clemens; Hauser-Kronberger, Cornelia; Egle, Alexander; Risch, Angela; Greil, Richard.
Affiliation
  • Gampenrieder SP; III rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (
  • Rinnerthaler G; III rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (
  • Hackl H; Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
  • Pulverer W; Center for Health & Bioresources, Business Unit for Molecular Diagnostics, AIT - Austrian Institute of Technology GmbH, Vienna, Austria.
  • Weinhaeusel A; Center for Health & Bioresources, Business Unit for Molecular Diagnostics, AIT - Austrian Institute of Technology GmbH, Vienna, Austria.
  • Ilic S; Center for Health & Bioresources, Business Unit for Molecular Diagnostics, AIT - Austrian Institute of Technology GmbH, Vienna, Austria.
  • Hufnagl C; Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hauser-Kronberger C; Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Egle A; III rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (
  • Risch A; Division of Cancer Genetics/Epigenetics, Department of Molecular Biology, University of Salzburg, Salzburg, Austria.
  • Greil R; Cancer Cluster Salzburg, Salzburg, Austria.
Theranostics ; 8(8): 2278-2288, 2018.
Article in En | MEDLINE | ID: mdl-29721079
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / DNA Methylation / Bevacizumab Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Theranostics Year: 2018 Document type: Article Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / DNA Methylation / Bevacizumab Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Theranostics Year: 2018 Document type: Article Country of publication: Australia